Trial
NCT03334240
ICVT in HPV-induced Genital Lesions of Immunocompromised and Immunocompetent Patients
Phase IITERMINATEDEFFICACY/FUTILITYConfidence: MEDIUM
Sponsor
Maruho Co., Ltd.
Collaborators
—
Condition
HPV-Induced Genital Lesions
Intervention
CLS003
Why stopped
Lack of effect in interim analysis
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-03-20